- Home
- NTHI vs HCAT Comparison
NTHI vs HCAT Comparison
Compare NTHI & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTHI | HCAT |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.5M | 174.0M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | NTHI | HCAT |
|---|---|---|
| Price | $10.19 | $2.45 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $4.30 |
| AVG Volume (30 Days) | 68.0K | ★ 800.9K |
| Earning Date | 11-14-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $59,990.00 | ★ $316,063,000.00 |
| Revenue This Year | N/A | $3.23 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.63 |
| 52 Week Low | $3.20 | $2.02 |
| 52 Week High | $25.00 | $8.50 |
Technical Indicators
Market Signals| Indicator | NTHI | HCAT |
|---|---|---|
| Relative Strength Index (RSI) | 58.54 | 40.95 |
| Support Level | $8.63 | $2.59 |
| Resistance Level | $9.75 | $3.03 |
| Average True Range (ATR) | 0.88 | 0.18 |
| MACD | 0.23 | -0.00 |
| Stochastic Oscillator | 95.59 | 27.65 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.